{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:50:23Z","timestamp":1790272223299,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.seizure.2025.07.023","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T21:14:59Z","timestamp":1754428499000},"page":"334-339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Intravenous perampanel in clinical practice: A multicenter prospective registry study"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8460-0015","authenticated-orcid":false,"given":"Yoshiki","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3962-9573","authenticated-orcid":false,"given":"Kenichiro","family":"Iwami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1566-9892","authenticated-orcid":false,"given":"Eriko","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiharu","family":"Ohka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhito","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4225-110X","authenticated-orcid":false,"given":"Shinsuke","family":"Muraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5346-6451","authenticated-orcid":false,"given":"Tomotaka","family":"Ishizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9346-1663","authenticated-orcid":false,"given":"Yoshitaka","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Shiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9270-2688","authenticated-orcid":false,"given":"Takenori","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Tanbara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Kano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihisa","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2484-1360","authenticated-orcid":false,"given":"Ryuta","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.seizure.2025.07.023_bib0001","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1528-1167.2005.00408.x","article-title":"Mortality in the first 30 days following incident acute symptomatic seizures","volume":"46","author":"Hesdorffer","year":"2005","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.seizure.2025.07.023_bib0002","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1528-1167.2008.01945.x","article-title":"Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure","volume":"50","author":"Hesdorffer","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2025.07.023_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.954986","article-title":"Acute symptomatic seizures and status epilepticus in older adults: a narrative review focusing on management and outcomes","volume":"13","author":"Kong","year":"2022","journal-title":"Front Neurol"},{"issue":"5","key":"10.1016\/j.seizure.2025.07.023_bib0004","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/mps7050079","article-title":"Prophylactic Administration of Perampanel for post-stroke epilepsy (PROPELLER Study): a trial protocol","volume":"7","author":"Yamada","year":"2024","journal-title":"Methods Protoc"},{"issue":"5","key":"10.1016\/j.seizure.2025.07.023_bib0005","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1474-4422(07)70103-5","article-title":"Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management","volume":"6","author":"van Breemen","year":"2007","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1016\/j.seizure.2025.07.023_bib0006","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1212\/WNL.0000000000001930","article-title":"Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy A randomized trial","volume":"85","author":"French","year":"2015","journal-title":"Neurology"},{"issue":"18","key":"10.1016\/j.seizure.2025.07.023_bib0007","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1212\/WNL.0b013e318254473a","article-title":"Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures","volume":"78","author":"Krauss","year":"2012","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.seizure.2025.07.023_bib0008","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1528-1167.2011.03109.x","article-title":"Perampanel: a novel, orally active, noncompetitive AMPA- receptor antagonist that reduces seizure activity in rodent models of epilepsy","volume":"52","author":"Hanada","year":"2011","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.seizure.2025.07.023_bib0009","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrneurol.2012.222","article-title":"Epilepsy: perampanel-new promise for refractory epilepsy?","volume":"8","author":"Loscher","year":"2012","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"10.1016\/j.seizure.2025.07.023_bib0010","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5698\/1535-7511-11.2.56","article-title":"Revisiting AMPA receptors as an antiepileptic drug target","volume":"11","author":"Rogawski","year":"2011","journal-title":"Epilepsy Curr"},{"issue":"1","key":"10.1016\/j.seizure.2025.07.023_bib0011","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/epi.12865","article-title":"The clinical pharmacology profile of the new antiepileptic drug perampanel: a novel noncompetitive AMPA receptor antagonist","volume":"56","author":"Patsalos","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2025.07.023_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108407","article-title":"Long-term efficacy and safety of perampanel as a first add-on therapy in patients with focal epilepsy: three-year extension study","volume":"125","author":"Im","year":"2021","journal-title":"Epilepsy Behav"},{"issue":"Pt A","key":"10.1016\/j.seizure.2025.07.023_bib0013","article-title":"Perampanel effectiveness and tolerability in patients with epilepsy at long-term follow-up","volume":"121","author":"Fernandes","year":"2021","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.seizure.2025.07.023_bib0014","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1684\/epd.2021.1369","article-title":"Evaluation of real- world effectiveness of perampanel in Japanese adults and older adults with epilepsy","volume":"24","author":"Inoue","year":"2022","journal-title":"Epileptic Disord"},{"issue":"5","key":"10.1016\/j.seizure.2025.07.023_bib0015","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1002\/epi4.13002","article-title":"Efficacy of perampanel by etiology in Japanese patients with epilepsy-subpopulation analysis of a prospective post-marketing observational study","volume":"9","author":"Nakai","year":"2024","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.seizure.2025.07.023_bib0016","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.seizure.2020.10.017","article-title":"Pharmacokinetics, tolerability, and clinical effectiveness of perampanel in Japanese patients with epilepsy","volume":"83","author":"Yamamoto","year":"2020","journal-title":"Seizure"},{"issue":"4","key":"10.1016\/j.seizure.2025.07.023_bib0017","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/epi4.12804","article-title":"Intravenous perampanel as an alternative to the oral formulations in Japanese patients with epilepsy","volume":"8","author":"Hanaya","year":"2023","journal-title":"Epilepsia Open"},{"issue":"7","key":"10.1016\/j.seizure.2025.07.023_bib0018","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/cpdd.1107","article-title":"Intravenous Perampanel as an interchangeable alternative to oral Perampanel: a randomized, crossover, phase I pharmacokinetic and safety study","volume":"11","author":"Hussein","year":"2022","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"2","key":"10.1016\/j.seizure.2025.07.023_bib0019","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/pharmrev.121.000375","article-title":"Post-traumatic epilepsy and comorbidities: advanced models, molecular mechanisms, biomarkers, and novel therapeutic interventions","volume":"74","author":"Golub","year":"2022","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.seizure.2025.07.023_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1141434","article-title":"Advances in understanding the pathogenesis of post-traumatic epilepsy: a literature review","volume":"14","author":"Fang","year":"2023","journal-title":"Front Neurol"},{"key":"10.1016\/j.seizure.2025.07.023_bib0021","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.seizure.2024.03.004","article-title":"Posttraumatic epilepsy in chronic disorders of consciousness due to severe traumatic brain injury after traffic accidents","volume":"117","author":"Yasuda","year":"2024","journal-title":"Seizure"},{"issue":"4","key":"10.1016\/j.seizure.2025.07.023_bib0022","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jocn.2014.09.019","article-title":"Epileptogenic focus localization in treatment-resistant post-traumatic epilepsy","volume":"22","author":"Irimia","year":"2014","journal-title":"J Clin Neurosci"},{"issue":"1","key":"10.1016\/j.seizure.2025.07.023_bib0023","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12883-016-0729-6","article-title":"Clinical predictors of seizure recurrence after the first post-ischemic stroke seizure","volume":"16","author":"Kim","year":"2016","journal-title":"BMC Neurol"},{"key":"10.1016\/j.seizure.2025.07.023_bib0024","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2147\/NDT.S473483","article-title":"Risk factors for post-stroke seizures in a tertiary care center: a case-control study","volume":"20","author":"Mohamed","year":"2024","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"1","key":"10.1016\/j.seizure.2025.07.023_bib0025","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3171\/2020.11.JNS202873","article-title":"Brain tumor-related epilepsy and risk factors for metastatic brain tumors: analysis of 601 consecutive cases providing real-world data","volume":"136","author":"Asano","year":"2021","journal-title":"J Neurosurg"},{"key":"10.1016\/j.seizure.2025.07.023_bib0026","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.seizure.2017.02.006","article-title":"Epidemiology of early stages of epilepsy: risk of seizure recurrence after a first seizure","volume":"49","author":"Rizvi","year":"2017","journal-title":"Seizure"},{"issue":"6","key":"10.1016\/j.seizure.2025.07.023_bib0027","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/epi.16548","article-title":"Effectiveness and safety of perampanel monotherapy for focal and generalized tonic-clonic seizures: experience from a national multicenter registry","volume":"61","author":"Toledano Delgado","year":"2020","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.seizure.2025.07.023_bib0028","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/epi4.12555","article-title":"A retrospective, real-world experience of perampanel monotherapy in patient with first new onset focal seizure: a Thailand experience","volume":"7","author":"Chinvarun","year":"2022","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.seizure.2025.07.023_bib0029","doi-asserted-by":"crossref","first-page":"287","DOI":"10.25259\/SNI_495_2023","article-title":"Perioperative perampanel administration for early seizure prophylaxis in brain tumor patients","volume":"14","author":"Kusakabe","year":"2023","journal-title":"Surg Neurol Int"},{"issue":"1","key":"10.1016\/j.seizure.2025.07.023_bib0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2176\/nmc.oa.2018-0245","article-title":"Experience of low dose perampanel to add-on in glioma patients with levetiracetam-uncontrollable epilepsy","volume":"60","author":"Chonan","year":"2020","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"10","key":"10.1016\/j.seizure.2025.07.023_bib0031","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1136\/jnnp-2014-308584","article-title":"Levetiracetam versus phenytoin for seizure prophylaxis during and early after craniotomy for brain tumours: a phase II prospective, randomised study","volume":"86","author":"Iuchi","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.seizure.2025.07.023_bib0032","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/ana.24522","article-title":"Predictors of preoperative and early postoperative seizures in patients with intra-axial primary and metastatic brain tumors: a retrospective observational single center study","volume":"78","author":"Skardelly","year":"2015","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.seizure.2025.07.023_bib0033","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s11912-023-01410-8","article-title":"Seizure management and prophylaxis considerations in patients with brain tumors","volume":"25","author":"Hauff","year":"2023","journal-title":"Curr Oncol Rep"},{"issue":"Suppl 1","key":"10.1016\/j.seizure.2025.07.023_bib0034","first-page":"i58","article-title":"Clinical management of seizures in patients with meningiomas: efficacy of surgical resection for seizure control and patient-tailored postoperative anti-epileptic drug management","volume":"5","author":"Peart","year":"2023","journal-title":"Neurooncol Adv"},{"issue":"23","key":"10.1016\/j.seizure.2025.07.023_bib0035","doi-asserted-by":"crossref","first-page":"10584","DOI":"10.1021\/jm301268u","article-title":"Discovery of 2-(2-oxo-1-phenyl-5-pyridin-2-yl-1,2-dihydropyridin-3-yl)benzonitrile (perampanel): a novel, noncompetitive \u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid (AMPA) receptor antagonist","volume":"55","author":"Hibi","year":"2012","journal-title":"J Med Chem"},{"issue":"5","key":"10.1016\/j.seizure.2025.07.023_bib0036","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.63","article-title":"Effect of perampanel, a novel AMPA antagonist, on benzodiazepine-resistant status epilepticus in a lithium-pilocarpine rat model","volume":"2","author":"Hanada","year":"2014","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.seizure.2025.07.023_bib0037","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neuint.2017.02.002","article-title":"Post-stroke epilepsy","volume":"107","author":"Tanaka","year":"2017","journal-title":"Neurochem Int"},{"issue":"1","key":"10.1016\/j.seizure.2025.07.023_bib0038","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12885-024-11846-1","article-title":"PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in patients with progressive glioblastoma","volume":"24","author":"Heuer","year":"2024","journal-title":"BMC Cancer"},{"issue":"7775","key":"10.1016\/j.seizure.2025.07.023_bib0039","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41586-019-1564-x","article-title":"Glutamatergic synaptic input to glioma cells drives brain tumour progression","volume":"573","author":"Venkataramani","year":"2019","journal-title":"Nature"},{"issue":"7775","key":"10.1016\/j.seizure.2025.07.023_bib0040","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41586-019-1563-y","article-title":"Electrical and synaptic integration of glioma into neural circuits","volume":"573","author":"Venkatesh","year":"2019","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.seizure.2025.07.023_bib0041","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3390\/cells10051226","article-title":"Glutamatergic mechanisms in glioblastoma and tumor-associated epilepsy","volume":"10","author":"Lange","year":"2021","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.seizure.2025.07.023_bib0042","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3892\/mco.2024.2740","article-title":"Optimizing perampanel monotherapy for surgically resected brain tumors","volume":"20","author":"Hino","year":"2024","journal-title":"Mol Clin Oncol"},{"issue":"10","key":"10.1016\/j.seizure.2025.07.023_bib0043","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/epi.14554","article-title":"Impact of carbamazepine, lamotrigine, and levetiracetam on vascular risk markers and lipid-lowering agents in the elderly","volume":"59","author":"Mintzer","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2025.07.023_bib0044","series-title":"UKCPA handbook of perioperative medicines [Internet]","article-title":"Perampanel","year":"2025"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131125001955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131125001955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:39:47Z","timestamp":1788244787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131125001955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":44,"alternative-id":["S1059131125001955"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2025.07.023","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous perampanel in clinical practice: A multicenter prospective registry study","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2025.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}